Ramipril 1.75 Mg Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 1.25 mg, 2.5 mg, 5 mg, 10 mg
Reference Brands: Tritace (EU), Ramace (India)
Category:
Hypertension
Ramipril Tablet is a drug that is used for the treatment of High Blood Pressure, Heart Failure mainly.
Ramipril 1.75 mg Tablets is available in Tablets
and strengths such as 1.25 mg, 2.5 mg, 5 mg, 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Ramipril 1.75 mg Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Ramipril 1.75 mg Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Ramipril Tablet is used for the treatment, control, prevention, & improvement of the following diseases and conditions: High Blood Pressure Heart Failure
Ramipril is an angiotensin-converting enzyme (ACE) inhibitor widely used for the management of cardiovascular conditions. Marketed under the brand name Altace by AstraZeneca, it is primarily indicated for the treatment of hypertension and for preventing the progression of heart failure in patients with a history of myocardial infarction.
Ramipril is also prescribed to reduce the risk of heart attack, stroke, and cardiovascular mortality in patients over 55 years of age who are at high risk of atherosclerotic disease or other severe cardiac events. It works by inhibiting the formation of angiotensin II, a hormone that constricts blood vessels, stimulates sympathetic activity, and promotes sodium and water retention in the kidneys. This inhibition leads to vasodilation, reduced blood pressure, and decreased cardiac workload.
Administered orally in tablet or capsule form, Ramipril is available in multiple strengths to allow individualized dosing based on patient needs, blood pressure response, and cardiovascular risk profile. With its proven efficacy and safety profile, Ramipril remains a cornerstone therapy in managing hypertension and reducing the risk of serious cardiovascular events.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing